Free Trial

Connect Biopharma (CNTB) SEC Filings & 10K Form

Connect Biopharma logo
$0.98 -0.08 (-7.92%)
(As of 05:26 PM ET)

Recent Connect Biopharma SEC Filings

DateFilerForm TypeView
09/06/2024
4:01 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
3:20 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
3:16 PM
Connect Biopharma (Subject)
Panacea Innovation Ltd (Filed by)
Form SC 13D/A
06/12/2024
3:47 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2024
4:00 PM
Connect Biopharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/16/2024
3:20 PM
Connect Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2024
8:00 PM
Connect Biopharma (Subject)
Panacea Innovation Ltd (Filed by)
Form SC 13D/A
02/13/2024
3:18 PM
Connect Biopharma (Subject)
Wei Zheng (Filed by)
Form SC 13G/A
12/20/2023
3:30 PM
Connect Biopharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
12/18/2023
5:44 PM
Connect Biopharma (Subject)
RA Capital Nexus Fund, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
5:09 PM
Connect Biopharma (Subject)
RA Capital Healthcare Fund LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CNTB) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners